GSK’S Introduction GlaxoSmithKline often abbreviated to GSK, is a global pharmaceutical, biologics, vaccines and consumer healthcare company headquartered in London, United Kingdom.
GSK’S Introduction It is world’s third largest pharmaceutical company measured by revenues ( after Johnson and Johnson and Pfizer. It has a portfolio of products for major disease areas including asthma, cancer, virus control, infections, mental health, diabetes and digestive conditions.
GlaxoSmithKline plc is a public limited company incorporated on 6th December 1999 under English law. Its shares are listed on the London Stock Exchange and the New York Stock Exchange.
On 27th December 2000 the company acquired Glaxo Wellcome plc and SmithKline Beecham plc, both English public limited companies, by way of a scheme of arrangement for the merger of the two companies.
History GSK and its subsidiary and associated undertakings constitute a major global healthcare group engaged in the creation, discovery, development, manufacture and marketing of pharmaceutical and consumer health-related products. GSK has its corporate head office in London and has its US headquarters in Research Triangle Park, North Carolina, with operations in some 120 countries, and products sold in over 150 countries.
Chairman: Sir Christopher Gent Chief Executive Officer: Andrew Witty
Grow a diversified global business – We are diversifying our business to create a more balanced product portfolio and move away from a reliance on traditional ‘white pill/western markets’. We are investing in key growth areas such as Emerging Markets, Japan, Vaccines and our Consumer Healthcare business.
Deliver more products of value – We aim to sustain an
industry-leading pipeline of products, ensuring that they demonstrate value for healthcare providers. Our R&D strategy is built around focusing on the best science, diversifying through externalisation of research, and improving the returns on investment.
Simplify the operating model – GSK is a large and complex organisation. We are transforming our operating model to reduce complexities, improve efficiency and reduce costs
Two other companies Stiefel, a GSK company— A Global Leader in Dermatology ViiV Healthcare — a global specialist HIV company established by GlaxoSmithKline and Pfizer to deliver advances in treatment and care for people
World market by geographic region value(billion pounds) % of total USA 187 40 Europe 131 28 France 25 5 Germany 24 5 Italy 16 3 UK 12 3 Rest of World 150 32 Emerging markets 66 14 Asia Pacific 20 4 Japan 50 11 Canada 11 2
Regional analysis (2009) (2008) cer% pnd% USA 9,180 8,894 (13) 3 Europe 7,681 6,483 9 18 Emerging Markets 2,973 2,290 20 30 Asia Pacific/Japan 2,700 1,918 16 41 Other trading‡ 1,180 796 31 48 23,714 20,381 2 16
CER% represents growth at constant exchange rates. Pound % growth at actual exchange rates.